These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2652626)

  • 21. In vitro humoral responses of renal allograft recipients.
    Paczek L; Gaciong Z; Korczak-Kowalska G; Nowaczyk M; Górski A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1595. PubMed ID: 2978884
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel series of low molecular weight immunosuppressive agents.
    Ocain TD; Bastos CM; Gordon KA; Granstein RD; Jenson JC; Jones B; McAuliffe DJ; Newcomb JR
    Transplant Proc; 1996 Dec; 28(6):3032-4. PubMed ID: 8962176
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 24. Pre-transplantation immunological monitoring and graft survival in recipients of renal allografts.
    Middleton D; Sleator C; McNeill TA; Merrett JD; Douglas JF; McGeown MG
    Clin Nephrol; 1984 Apr; 21(4):223-9. PubMed ID: 6375925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro studies of the human response to organ allografts: appearance and detection of circulating activation lymphocytes.
    Hersh EM; Butler WT; Rossen RD; Morgan RO; Suki W
    J Immunol; 1971 Aug; 107(2):571-8. PubMed ID: 4936291
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prognostic and differentiating value of cellular nonspecific immune monitoring following kidney allotransplantation].
    Rasheva M; Stefanov G
    Vutr Boles; 1985; 24(4):47-55. PubMed ID: 3907145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 28. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rejection of human liver allografts: immuno-histopathologic relationship and direct allorecognition of donor antigens by T lymphocytes.
    Arvieux C; Drouet C; Pasquier D; Zarski JP; Barnoud D; Granger P; Delannoy P; Letoublon C
    Transplant Proc; 1996 Oct; 28(5):2849-50. PubMed ID: 8908097
    [No Abstract]   [Full Text] [Related]  

  • 30. Histopathological changes in canine renal allotransplants after yeast respiratory extract (PCO) treatment.
    Groenewald JH; Weber HW; Mirand EA; Murphy GP
    Am Surg; 1971 May; 37(5):281-6. PubMed ID: 4930631
    [No Abstract]   [Full Text] [Related]  

  • 31. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphocyte transformation in renal lymphatics during canine allograft rejection.
    Cockett AT; Sakai A; Netto IC
    Invest Urol; 1973 Sep; 11(2):160-4. PubMed ID: 4580545
    [No Abstract]   [Full Text] [Related]  

  • 33. OKT3 rescue therapy for 63 refractory rejections in 405 renal allografts.
    Uchida K; Namii Y; Tominaga Y; Haba T; Tanaka H; Ichimori T; Uemura O; Morozumi K; Hayashi S; Yokoyama J; Takagi H
    Transplant Proc; 1996 Jun; 28(3):1358-9. PubMed ID: 8658693
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitation of soluble forms of HLA in kidney transplantation.
    Shimura T; Hagihara M; Yamamoto K; Takebe K; Munkhbat B; Tsuji K
    Transplant Proc; 1994 Aug; 26(4):1891. PubMed ID: 8066614
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphocyte activation during allograft rejection.
    Hersh EM; Butler WT; Rossen RD; Morgen RO; Suki W
    Transplant Proc; 1971 Mar; 3(1):457-60. PubMed ID: 4937918
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of serum neopterin levels and spontaneous blastogenesis in monitoring of kidney graft recipients.
    Pohanka E; Zlabinger GJ; Mayer G; Woloszcsuk W; Kovarik J; Smolen J; SteffenC
    Transplant Proc; 1988 Feb; 20(1):110-5. PubMed ID: 3278451
    [No Abstract]   [Full Text] [Related]  

  • 37. Biological characteristics of a novel immunosuppressant, IR-1116, specific for B lymphocytes.
    Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):734-7. PubMed ID: 8382385
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of immunosuppressive agents and matching on pulmonary allografts.
    Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
    Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro immunoresponsiveness in recipients of cadaveric renal allografts during ATG therapy.
    Grosse-Wilde H; Jakubowski HD; Eigler FW; Kuwert EK
    Proc Eur Dial Transplant Assoc; 1981; 18():481-5. PubMed ID: 7036170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rejection monitoring by lymphocyte blastogenesis assay in canine lung allotransplantation.
    Fujimura S; Kondo T; Yamauchi A; Okabe T; Handa M; Shionozaki F; Saito R; Horikawa M; Nakada T
    Tohoku J Exp Med; 1984 Mar; 142(3):321-35. PubMed ID: 6233754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.